Integra Lifesciences Holdings (IART) Finished Goods (2010 - 2017)

Integra Lifesciences Holdings (IART) reported Finished Goods of $136.7 million for Q3 2017, up 6.84% sequentially from $128.0 million in Q4 2016.

Integra Lifesciences Holdings (IART) Finished Goods (2010 - 2017) Analysis & Trends

Integra Lifesciences Holdings (IART) has 7 years of Finished Goods data on file, last reported at $136.7 million in Q3 2017.

  • For the quarter ending Q3 2017, Finished Goods changed N/A year-over-year to $136.7 million; the trailing twelve-month figure through Sep 2017 stood at $136.7 million (changed N/A YoY), and the FY2016 full-year result was $128.0 million, changed N/A from the prior year.
  • Finished Goods advanced to $136.7 million in Q3 2017, from $128.0 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $150.5 million in Q4 2014 to a low of $128.0 million in Q4 2016.
  • A 4-year average of $140.5 million and a median of $141.8 million in 2015 frame the typical range for Finished Goods.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Integra Lifesciences Holdings 1.71 Bn 1.45 Bn 216.98 Mn

Historic Data

Download Data
DateValue
Sep 30, 2017 136.73 Mn
Dec 31, 2016 127.97 Mn
Jun 30, 2015 146.91 Mn
Dec 31, 2014 150.48 Mn
Jun 30, 2012 107.12 Mn
Mar 31, 2012 108.43 Mn
Dec 31, 2011 106.97 Mn
Sep 30, 2011 112.55 Mn
Jun 30, 2011 109.07 Mn
Dec 31, 2010 87.51 Mn